Page last updated: 2024-10-26

valproic acid and Glycine Encephalopathy

valproic acid has been researched along with Glycine Encephalopathy in 5 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
"Nonketotic hyperglycinemia (NKH), or glycine encephalopathy, is an autosomal recessive disorder caused by a defect in the glycine cleavage enzyme system."1.38Paradoxical increase in seizure frequency with valproate in nonketotic hyperglycinemia. ( Aida, N; Iai, M; Kure, S; Osaka, H; Shimbo, H; Tsuji, M; Tsuyusaki, Y; Wada, T; Yamashita, S, 2012)
"Hyperglycinemia was induced in healthy vervet monkeys when treated with a single oral dose of 50 mg/kg valproate."1.38Paracetamol prevents hyperglycinemia in vervet monkeys treated with valproate. ( Bergh, JJ; Kotze, HF; Mienie, LJ; Terre'Blanche, G; Viljoen, J, 2012)
"An important subset of children with nonketotic hyperglycinemia are atypical variants who present in a heterogeneous manner."1.33Valproate-induced chorea and encephalopathy in atypical nonketotic hyperglycinemia. ( Morrison, PF; Sankar, R; Shields, WD, 2006)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsuyusaki, Y1
Shimbo, H1
Wada, T1
Iai, M1
Tsuji, M1
Yamashita, S1
Aida, N1
Kure, S1
Osaka, H1
Viljoen, J1
Bergh, JJ1
Mienie, LJ1
Kotze, HF1
Terre'Blanche, G1
Chen, PS1
Yang, YK1
Yeh, TL1
Lo, YC1
Wang, YT1
Morrison, PF1
Sankar, R1
Shields, WD1
Korman, SH1

Other Studies

5 other studies available for valproic acid and Glycine Encephalopathy

ArticleYear
Paradoxical increase in seizure frequency with valproate in nonketotic hyperglycinemia.
    Brain & development, 2012, Volume: 34, Issue:1

    Topics: Anticonvulsants; Brain; Child; Dextromethorphan; Excitatory Amino Acid Antagonists; Female; Humans;

2012
Paracetamol prevents hyperglycinemia in vervet monkeys treated with valproate.
    Metabolic brain disease, 2012, Volume: 27, Issue:3

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anticonvulsants; Chlorocebus aethiops; Disease Mod

2012
Nonketotic hyperosmolar syndrome from olanzapine, lithium, and valproic acid cotreatment.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:6

    Topics: Adult; Benzodiazepines; Drug Therapy, Combination; Humans; Hyperglycinemia, Nonketotic; Lithium Chlo

2003
Valproate-induced chorea and encephalopathy in atypical nonketotic hyperglycinemia.
    Pediatric neurology, 2006, Volume: 35, Issue:5

    Topics: Anticonvulsants; Brain Diseases; Child; Chorea; Female; Humans; Hyperglycinemia, Nonketotic; Valproi

2006
Diagnosis of nonketotic hyperglycinemia in patients treated with valproic acid.
    Pediatric neurology, 2007, Volume: 37, Issue:1

    Topics: Anticonvulsants; Child; Diagnosis, Differential; Female; Humans; Hyperglycinemia, Nonketotic; Infant

2007